scholarly article | Q13442814 |
P50 | author | Hans-Dieter Klenk | Q1576857 |
Guan Yi | Q8962817 | ||
P2093 | author name string | Wolfgang Garten | |
Eva Böttcher-Friebertshäuser | |||
Carolin Tarnow | |||
Folker Schwalm | |||
Daniela Meyer | |||
Torsten Steinmetzer | |||
Joanna Baron | |||
Maya Hammami | |||
Deborah Mayoli-Nüssle | |||
Eva Schilling | |||
P2860 | cites work | New low-viscosity overlay medium for viral plaque assays | Q21245137 |
Evaluation of Pathogenic Potential of Avian Influenza Virus Serotype H9N2 in Chickens | Q22305893 | ||
Reverse biochemistry: use of macromolecular protease inhibitors to dissect complex biological processes and identify a membrane-type serine protease in epithelial cancer and normal tissue | Q24614528 | ||
Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium | Q24671018 | ||
Molecular characterization of H9N2 influenza viruses: were they the donors of the "internal" genes of H5N1 viruses in Hong Kong? | Q24684322 | ||
Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation | Q27766025 | ||
Matriptase and its putative role in cancer | Q28275949 | ||
A DNA transfection system for generation of influenza A virus from eight plasmids | Q29642855 | ||
Role of hemagglutinin cleavage for the pathogenicity of influenza virus. | Q30322358 | ||
Cocirculation of avian H9N2 and contemporary "human" H3N2 influenza A viruses in pigs in southeastern China: potential for genetic reassortment? | Q30328654 | ||
The genesis and evolution of H9N2 influenza viruses in poultry from southern China, 2000 to 2005 | Q30363051 | ||
Minimal molecular constraints for respiratory droplet transmission of an avian-human H9N2 influenza A virus | Q30376280 | ||
Cleavage of influenza virus hemagglutinin by airway proteases TMPRSS2 and HAT differs in subcellular localization and susceptibility to protease inhibitors | Q30386796 | ||
Avian influenza virus infections. I. Characteristics of influenza A-turkey-Wisconsin-1966 virus. | Q45822667 | ||
Probing the substrate specificities of matriptase, matriptase-2, hepsin and DESC1 with internally quenched fluorescent peptides | Q46080677 | ||
Universal primer set for the full-length amplification of all influenza A viruses | Q57202943 | ||
Secondary amides of sulfonylated 3-amidinophenylalanine. New potent and selective inhibitors of matriptase | Q79842080 | ||
Inhibition of influenza virus infection in human airway cell cultures by an antisense peptide-conjugated morpholino oligomer targeting the hemagglutinin-activating protease TMPRSS2. | Q30396910 | ||
High genetic compatibility and increased pathogenicity of reassortants derived from avian H9N2 and pandemic H1N1/2009 influenza viruses | Q30400353 | ||
Phylogeography and evolutionary history of reassortant H9N2 viruses with potential human health implications | Q30403938 | ||
Compatibility of H9N2 avian influenza surface genes and 2009 pandemic H1N1 internal genes for transmission in the ferret model | Q30404488 | ||
A distinct lineage of influenza A virus from bats | Q30413578 | ||
A novel mechanism for the acquisition of virulence by a human influenza A virus | Q30431264 | ||
Overexpression of the alpha-2,6-sialyltransferase in MDCK cells increases influenza virus sensitivity to neuraminidase inhibitors | Q30452892 | ||
Expression of transmembrane serine protease TMPRSS2 in mouse and human tissues | Q31910018 | ||
Membrane-anchored serine protease matriptase regulates epithelial barrier formation and permeability in the intestine | Q33732689 | ||
Live bird markets of Bangladesh: H9N2 viruses and the near absence of highly pathogenic H5N1 influenza | Q33889293 | ||
Modifications to the hemagglutinin cleavage site control the virulence of a neurotropic H1N1 influenza virus | Q34055445 | ||
TMPRSS2 and TMPRSS4 facilitate trypsin-independent spread of influenza virus in Caco-2 cells. | Q34120814 | ||
Molecular basis of efficient replication and pathogenicity of H9N2 avian influenza viruses in mice | Q34328675 | ||
Endogenous expression of matriptase in neural progenitor cells promotes cell migration and neuron differentiation | Q34568589 | ||
Matriptase: potent proteolysis on the cell surface | Q34809525 | ||
Highly potent inhibitors of proprotein convertase furin as potential drugs for treatment of infectious diseases | Q36052463 | ||
Cleavage activation of the human-adapted influenza virus subtypes by matriptase reveals both subtype and strain specificities | Q36276614 | ||
An overlapping protein-coding region in influenza A virus segment 3 modulates the host response | Q36554219 | ||
Hepatocyte growth factor activator inhibitor-1 has a complex subcellular itinerary | Q36753781 | ||
Potent inhibition and global co-localization implicate the transmembrane Kunitz-type serine protease inhibitor hepatocyte growth factor activator inhibitor-2 in the regulation of epithelial matriptase activity | Q36944800 | ||
Type II transmembrane serine proteases in development and disease | Q37055730 | ||
Proteolytic activation of the 1918 influenza virus hemagglutinin | Q37127965 | ||
Polarized epithelial cells secrete matriptase as a consequence of zymogen activation and HAI-1-mediated inhibition | Q37298015 | ||
H9 avian influenza reassortant with engineered polybasic cleavage site displays a highly pathogenic phenotype in chicken | Q39551904 | ||
H9N2 influenza virus acquires intravenous pathogenicity on the introduction of a pair of di-basic amino acid residues at the cleavage site of the hemagglutinin and consecutive passages in chickens | Q39594620 | ||
Novel type II transmembrane serine proteases, MSPL and TMPRSS13, Proteolytically activate membrane fusion activity of the hemagglutinin of highly pathogenic avian influenza viruses and induce their multicycle replication | Q39729350 | ||
MDCK cells that express proteases TMPRSS2 and HAT provide a cell system to propagate influenza viruses in the absence of trypsin and to study cleavage of HA and its inhibition | Q39785883 | ||
Activation of influenza A viruses by trypsin treatment | Q39965584 | ||
In vitro inhibition of matriptase prevents invasive growth of cell lines of prostate and colon carcinoma | Q40377367 | ||
Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease | Q41505675 | ||
Molecular quantitation of H9N2 avian influenza virus in various organs of broiler chickens using TaqMan real time PCR. | Q42145753 | ||
Amino acid 226 in the hemagglutinin of H9N2 influenza viruses determines cell tropism and replication in human airway epithelial cells | Q42737927 | ||
Avian influenza infection in birds: a challenge and opportunity for the poultry veterinarian | Q43175096 | ||
Human infection with influenza H9N2. | Q43209306 | ||
Characterization of the pathogenicity of members of the newly established H9N2 influenza virus lineages in Asia | Q43209344 | ||
H9N2 influenza A viruses from poultry in Asia have human virus-like receptor specificity | Q43209491 | ||
Natural cases and an experimental study of H9N2 avian influenza in commercial broiler chickens of Iran. | Q43209713 | ||
Characterization of matriptase expression in normal human tissues | Q44519409 | ||
Is virulence of H5N2 influenza viruses in chickens associated with loss of carbohydrate from the hemagglutinin? | Q44730162 | ||
P433 | issue | 3 | |
P304 | page(s) | 1811-1820 | |
P577 | publication date | 2012-11-28 | |
P1433 | published in | Journal of Virology | Q1251128 |
P1476 | title | Matriptase, HAT, and TMPRSS2 activate the hemagglutinin of H9N2 influenza A viruses | |
P478 | volume | 87 |
Q50754826 | A Fluorescent-Labeled Phosphono Bisbenzguanidine As an Activity-Based Probe for Matriptase. |
Q30355823 | A novel activation mechanism of avian influenza virus H9N2 by furin. |
Q30400507 | A peptide-based approach to evaluate the adaptability of influenza A virus to humans based on its hemagglutinin proteolytic cleavage site |
Q41820530 | Activation of influenza A viruses by host proteases from swine airway epithelium |
Q38118946 | Activation of influenza viruses by proteases from host cells and bacteria in the human airway epithelium |
Q39246178 | Airway proteases: an emerging drug target for influenza and other respiratory virus infections. |
Q97070776 | Assessment of low pathogenic avian influenza virus transmission via raw poultry meat and raw table eggs |
Q60922594 | Association of Increased Receptor-Binding Avidity of Influenza A(H9N2) Viruses with Escape from Antibody-Based Immunity and Enhanced Zoonotic Potential |
Q37066934 | Cell Surface Human Airway Trypsin-Like Protease Is Lost During Squamous Cell Carcinogenesis |
Q53099256 | Changing the selectivity profile - from substrate analog inhibitors of thrombin and factor Xa to potent matriptase inhibitors. |
Q37526173 | Composition of the Hemagglutinin Polybasic Proteolytic Cleavage Motif Mediates Variable Virulence of H7N7 Avian Influenza Viruses |
Q30365699 | DESC1 and MSPL activate influenza A viruses and emerging coronaviruses for host cell entry. |
Q48363355 | Design and chemical syntheses of potent matriptase-2 inhibitors based on trypsin inhibitor SFTI-1 isolated from sunflower seeds. |
Q27684175 | Discovery of Pyridyl Bis(oxy)dibenzimidamide Derivatives as Selective Matriptase Inhibitors |
Q59349851 | Evidence of a fixed internal gene constellation in influenza A viruses isolated from wild birds in Argentina (2006-2016) |
Q58690963 | Exchange of amino acids in the H1-haemagglutinin to H3 residues is required for efficient influenza A virus replication and pathology in Tmprss2 knock-out mice |
Q104440003 | Furin cleavage of SARS-CoV-2 Spike promotes but is not essential for infection and cell-cell fusion |
Q107108504 | Furin cleavage of SARS-CoV-2 Spike promotes but is not essential for infection and cell-cell fusion |
Q66678731 | Furin-mediated protein processing in infectious diseases and cancer |
Q43168053 | Genetic characterization of H9N2 avian influenza viruses isolated from poultry in Poland during 2013/2014. |
Q24329267 | HATL5: a cell surface serine protease differentially expressed in epithelial cancers |
Q90616727 | Hemagglutinin Cleavability, Acid Stability, and Temperature Dependence Optimize Influenza B Virus for Replication in Human Airways |
Q37706501 | High TMPRSS11D protein expression predicts poor overall survival in non-small cell lung cancer. |
Q39149977 | Human airway trypsin-like protease, a serine protease involved in respiratory diseases |
Q91837774 | Human matriptase/ST 14 proteolytically cleaves H7N9 hemagglutinin and facilitates the activation of influenza A/Shanghai/2/2013 virus in cell culture |
Q37358618 | Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay. |
Q90035271 | Influenza A virus infection induces liver injury in mice |
Q35177555 | Influenza virus adaptation PB2-627K modulates nucleocapsid inhibition by the pathogen sensor RIG-I. |
Q90001154 | Iterative, multiplexed CRISPR-mediated gene editing for functional analysis of complex protease gene clusters |
Q30426551 | Matriptase proteolytically activates influenza virus and promotes multicycle replication in the human airway epithelium |
Q104073718 | Non-basic amino acids in the hemagglutinin proteolytic cleavage site of a European H9N2 avian influenza virus modulate virulence in turkeys |
Q33663432 | Non-human primate orthologues of TMPRSS2 cleave and activate the influenza virus hemagglutinin |
Q37284207 | Prevalence and diversity of H9N2 avian influenza in chickens of Northern Vietnam, 2014. |
Q30354466 | Proteolytic activation of the SARS-coronavirus spike protein: cutting enzymes at the cutting edge of antiviral research. |
Q36104532 | Respiratory protease/antiprotease balance determines susceptibility to viral infection and can be modified by nutritional antioxidants |
Q35009468 | Role of the spike glycoprotein of human Middle East respiratory syndrome coronavirus (MERS-CoV) in virus entry and syncytia formation |
Q89709684 | SPINT2 inhibits proteases involved in activation of both influenza viruses and metapneumoviruses |
Q57252412 | TMPRSS11A activates the influenza A virus hemagglutinin and the MERS coronavirus spike protein and is insensitive against blockade by HAI-1 |
Q95602650 | TMPRSS2 and TMPRSS4 mediate SARS-CoV-2 infection of human small intestinal enterocytes |
Q94670006 | TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes |
Q97680833 | TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells |
Q37713993 | TMPRSS2 is a host factor that is essential for pneumotropism and pathogenicity of H7N9 influenza A virus in mice |
Q35974128 | The Hemagglutinin of Bat-Associated Influenza Viruses Is Activated by TMPRSS2 for pH-Dependent Entry into Bat but Not Human Cells |
Q90040549 | The Proteolytic Regulation of Virus Cell Entry by Furin and Other Proprotein Convertases |
Q91800481 | The evolution and genetic diversity of avian influenza A(H9N2) viruses in Cambodia, 2015 - 2016 |
Q33602849 | The host protease TMPRSS2 plays a major role in in vivo replication of emerging H7N9 and seasonal influenza viruses |
Q40058871 | Type II transmembrane serine proteases as potential target for anti-influenza drug discovery |
Q54216660 | Unexpected infection outcomes of China-origin H7N9 low pathogenicity avian influenza virus in turkeys. |
Q38850386 | Use of AAScatterPlot tool for monitoring the evolution of the hemagglutinin cleavage site in H9 avian influenza viruses |
Q40949630 | Variability of tropism and replicative capacity of two naturally occurring influenza A H9N2 viruses in cell cultures from different tissues |
Search more.